Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

Is there "brain OAB" and how can we recognize it? International Consultation on Incontinence-Research Society (ICI-RS) 2017.

Apostolidis A, Wagg A, Rahnam A'i MS, Panicker JN, Vrijens D, von Gontard A.

Neurourol Urodyn. 2018 Feb 1. doi: 10.1002/nau.23506. [Epub ahead of print]

PMID:
29388707
2.

Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.

van Eijk RPA, Jones AR, Sproviero W, Shatunov A, Shaw PJ, Leigh PN, Young CA, Shaw CE, Mora G, Mandrioli J, Borghero G, Volanti P, Diekstra FP, van Rheenen W, Verstraete E, Eijkemans MJC, Veldink JH, Chio A, Al-Chalabi A, van den Berg LH, van Es MA; For UKMND-LiCALS and LITALS Study Group.

Neurology. 2017 Oct 31;89(18):1915-1922. doi: 10.1212/WNL.0000000000004606. Epub 2017 Oct 4. Review. Erratum in: Neurology. 2017 Nov 28;89(22):2303.

3.

Urinary, bowel and sexual symptoms in a cohort of patients with Friedreich's ataxia.

Lad M, Parkinson MH, Rai M, Pandolfo M, Bogdanova-Mihaylova P, Walsh RA, Murphy S, Emmanuel A, Panicker J, Giunti P.

Orphanet J Rare Dis. 2017 Sep 26;12(1):158. doi: 10.1186/s13023-017-0709-y.

4.

Does the appearance of the urethral pressure profile trace correlate with the sphincter EMG findings in women with voiding dysfunction?

Sihra N, Malde S, Panicker J, Kightley R, Solomon E, Hamid R, Ockrim J, Greenwell TJ, Pakzad M.

Neurourol Urodyn. 2017 Jul 5. doi: 10.1002/nau.23341. [Epub ahead of print]

PMID:
28678412
5.

Neurogenic bowel dysfunction: Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013.

Cotterill N, Madersbacher H, Wyndaele JJ, Apostolidis A, Drake MJ, Gajewski J, Heesakkers J, Panicker J, Radziszewski P, Sakakibara R, Sievert KD, Hamid R, Kessler TM, Emmanuel A.

Neurourol Urodyn. 2018 Jan;37(1):46-53. doi: 10.1002/nau.23289. Epub 2017 Jun 22. Review.

PMID:
28640977
6.

Urogenital Symptoms in Neurologic Patients.

Panicker JN.

Continuum (Minneap Minn). 2017 Apr;23(2, Selected Topics in Outpatient Neurology):533-552. doi: 10.1212/CON.0000000000000448.

PMID:
28375917
7.

Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.

Abo Youssef N, Schneider MP, Mordasini L, Ineichen BV, Bachmann LM, Chartier-Kastler E, Panicker JN, Kessler TM.

BJU Int. 2017 Apr;119(4):515-521. doi: 10.1111/bju.13759. Epub 2017 Feb 23. Review.

8.

Open label feasibility study evaluating D-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosis.

Phé V, Pakzad M, Haslam C, Gonzales G, Curtis C, Porter B, Chataway J, Panicker JN.

Neurourol Urodyn. 2017 Sep;36(7):1770-1775. doi: 10.1002/nau.23173. Epub 2016 Nov 4.

PMID:
27813195
9.

Urologic symptoms and functional neurologic disorders.

Hoeritzauer I, Phé V, Panicker JN.

Handb Clin Neurol. 2016;139:469-481. doi: 10.1016/B978-0-12-801772-2.00038-2. Review.

PMID:
27719863
10.

Treatment Options for Urogenital Dysfunction in Parkinson's Disease.

Batla A, Tayim N, Pakzad M, Panicker JN.

Curr Treat Options Neurol. 2016 Oct;18(10):45. doi: 10.1007/s11940-016-0427-0. Review.

11.

Neurogenic lower urinary tract dysfunction: evaluation and management.

Tudor KI, Sakakibara R, Panicker JN.

J Neurol. 2016 Dec;263(12):2555-2564. Epub 2016 Jul 11. Review.

PMID:
27401178
12.

Neurogenic lower urinary tract dysfunction: Clinical management recommendations of the Neurologic Incontinence committee of the fifth International Consultation on Incontinence 2013.

Drake MJ, Apostolidis A, Cocci A, Emmanuel A, Gajewski JB, Harrison SC, Heesakkers JP, Lemack GE, Madersbacher H, Panicker JN, Radziszewski P, Sakakibara R, Wyndaele JJ.

Neurourol Urodyn. 2016 Aug;35(6):657-65. doi: 10.1002/nau.23027. Epub 2016 May 13. Review.

PMID:
27176559
13.

Management of neurogenic bladder in patients with multiple sclerosis.

Phé V, Chartier-Kastler E, Panicker JN.

Nat Rev Urol. 2016 May;13(5):275-88. doi: 10.1038/nrurol.2016.53. Epub 2016 Mar 31. Review.

PMID:
27030526
14.

Urinary tract infections in multiple sclerosis.

Phé V, Pakzad M, Curtis C, Porter B, Haslam C, Chataway J, Panicker JN.

Mult Scler. 2016 Jun;22(7):855-61. doi: 10.1177/1352458516633903. Epub 2016 Feb 18. Review.

PMID:
26892318
15.

Lower urinary tract dysfunction in patients with functional movement disorders.

Batla A, Pareés I, Edwards MJ, Stamelou M, Bhatia KP, Panicker JN.

J Neurol Sci. 2016 Feb 15;361:192-4. doi: 10.1016/j.jns.2015.12.048. Epub 2015 Dec 29.

PMID:
26810540
16.

Mycobacterium chelonae Infection Involving a Percutaneous Gastrostomy Tube Tract in a Seven-year-old Child With Acute Lymphoblastic Leukemia.

Nabaah A, Jackson MA, Myers A, Panicker J.

Pediatr Infect Dis J. 2016 Feb;35(2):225-6. doi: 10.1097/INF.0000000000000976. No abstract available.

PMID:
26756265
17.

Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity.

Ballouhey Q, Panicker JN, Mazerolles C, Roumiguie M, Zaidi F, Rischmann P, Malavaud B, Game X.

Int Braz J Urol. 2015 Nov-Dec;41(6):1141-7. doi: 10.1590/S1677-5538.IBJU.2014.0676.

18.

Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder.

Mutch K, Zhao S, Hamid S, Methley A, Elsone L, Singh G, Young C, Emmanuel A, Panicker J, Jacob A.

Mult Scler Relat Disord. 2015 Nov;4(6):614-8. doi: 10.1016/j.msard.2015.07.015. Epub 2015 Jul 30.

PMID:
26590671
19.

Évaluation de l'effet sur la qualité de vie du mirabégron dans le traitement de l'hyperactivité vésicale chez les patients neurologiques.

Phe V, Mukhtar B, Couchman A, Grewal M, Hamid R, Ockrim J, Greenwell T, Panicker J, Pakzad M.

Prog Urol. 2015 Nov;25(13):845-6. doi: 10.1016/j.purol.2015.08.260. French. No abstract available.

PMID:
26544453
20.

Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome).

Panicker JN, Seth JH, Khan S, Gonzales G, Haslam C, Kessler TM, Fowler CJ.

BJU Int. 2016 May;117(5):809-13. doi: 10.1111/bju.13342. Epub 2015 Nov 8.

Supplemental Content

Loading ...
Support Center